Literature DB >> 8561849

Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases.

T Pourmotabbed1, J A Aelion, D Tyrrell, K A Hasty, C H Bu, C L Mainardi.   

Abstract

Gelatinase B (MMP-9), a member of the matrix metalloproteinase family, is a zinc- and calcium-dependent endopeptidase that is known to play a role in tumor cell invasion and in destruction of cartilage in arthritis. It contains a conserved sequence. 400His-(X)3-His-(X)28-Asp-Asp-(X)2-436Gly, the function of which is under investigation. The conserved Asp-432 and Asp-433 residues were individually replaced with Gly; these substitutions reduced the gelatinolytic activity of the enzyme to 23% and 0%, respectively. Replacing Asp-433 with Glu, however, decreased the gelatinolytic activity of the enzyme by 93% and proteolytic activity of the enzyme for the Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate by 79%. The wild-type and D432G and D433E, mutant enzymes had similar Km values for the synthetic substrate and similar Ki values for the competitive inhibitor, GM6001. The kcat/Km values for D432G and D433E mutant enzymes, however, were reduced by a factor of approximately 4 and their KaCa values were increased by four- and sixfold, respectively. The significance of His-400 in the activity of the enzyme was assessed by replacing this residue with Ala and Phe. Both H400A and H400F mutants were inactive toward gelatin substrate. These data demonstrate that Asp-432, Asp-433, and His-400 residues are important for the activity of gelatinase B. His-400 may act as a zinc-binding ligand similar to the His-197 in interstitial collagenase (MMP-7) and Asp-432 and Asp-433 residues are probably involved in stabilization of the active site of the enzyme. The His-400 and Asp-433 residues are conserved in all members of the MMP family. Therefore, our results are relevant to this group as a whole.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8561849     DOI: 10.1007/bf01886879

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  44 in total

1.  The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin.

Authors:  J Saus; S Quinones; Y Otani; H Nagase; E D Harris; M Kurkinen
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

2.  Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.

Authors:  O A Alvarez; D F Carmichael; Y A DeClerck
Journal:  J Natl Cancer Inst       Date:  1990-04-04       Impact factor: 13.506

3.  Structure of human neutrophil collagenase reveals large S1' specificity pocket.

Authors:  T Stams; J C Spurlino; D L Smith; R C Wahl; T F Ho; M W Qoronfleh; T M Banks; B Rubin
Journal:  Nat Struct Biol       Date:  1994-02

4.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

5.  Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; S B Gruber; R J Muschel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study.

Authors:  P Reinemer; F Grams; R Huber; T Kleine; S Schnierer; M Piper; H Tschesche; W Bode
Journal:  FEBS Lett       Date:  1994-01-31       Impact factor: 4.124

7.  Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.

Authors:  B Lovejoy; A Cleasby; A M Hassell; K Longley; M A Luther; D Weigl; G McGeehan; A B McElroy; D Drewry; M H Lambert
Journal:  Science       Date:  1994-01-21       Impact factor: 47.728

8.  The NMR structure of the inhibited catalytic domain of human stromelysin-1.

Authors:  P R Gooley; J F O'Connell; A I Marcy; G C Cuca; S P Salowe; B L Bush; J D Hermes; C K Esser; W K Hagmann; J P Springer
Journal:  Nat Struct Biol       Date:  1994-02

9.  Assignments for the main-chain nuclear magnetic resonances and delineation of the secondary structure of the catalytic domain of human stromelysin-1 as obtained from triple-resonance 3D NMR experiments.

Authors:  S R Van Doren; A V Kurochkin; Q Z Ye; L L Johnson; D J Hupe; E R Zuiderweg
Journal:  Biochemistry       Date:  1993-12-07       Impact factor: 3.162

10.  The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.

Authors:  W Bode; P Reinemer; R Huber; T Kleine; S Schnierer; H Tschesche
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more
  1 in total

1.  The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.

Authors:  Ingebrigt Sylte; Rangita Dawadi; Nabin Malla; Susannah von Hofsten; Tra-Mi Nguyen; Ann Iren Solli; Eli Berg; Olayiwola A Adekoya; Gunbjørg Svineng; Jan-Olof Winberg
Journal:  PLoS One       Date:  2018-08-03       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.